ArticleScientific reports2025

Phase I study of pevonedistat combined with capecitabine and oxaliplatin in patients with platinum-refractory advanced gastric cancer.

Hirokazu Shoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.